Sean RuddFolks interested in #CancerDrugDevelopment should check this months edition of #MolecularOncology 👇
https://febs.onlinelibrary.wiley.com/toc/18780261/2022/16/21
A thematic issue with excellent reviews on #DrugResistance #DrugDevelopment and #DrugDesign
We also contributed a review on targeting dNTP #metabolism in cancer, which we discuss in the context of (selectively) inducing DNA lesions in cancer cells and in the refinement of current antimetabolite based therapies